• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Angiogenic Factors Regulate Tumorigenicity and Metastasis of Human Transitional Cell Carcinoma in the Urinary Bladder

Research Project

Project/Area Number 12671540
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKochi Medical School

Principal Investigator

INOUE Keiji  Kochi Medical School, Assistant Professor, 医学部, 講師 (00294827)

Co-Investigator(Kenkyū-buntansha) SHUIN Taro  Kochi Medical School, Professor, 医学部, 教授 (80179019)
KAMADA Masayuki  Kochi Medical School, Research Associate, 医学部・附属病院, 助手 (90304683)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2001: ¥200,000 (Direct Cost: ¥200,000)
Fiscal Year 2000: ¥3,400,000 (Direct Cost: ¥3,400,000)
Keywordsangiogenesis / tumorigenicity / metastasis / transitional cell carcinoma / VEGF / bFGF / IL-8 / 膀胱移行上皮癌 / 浸潤
Research Abstract

Purpose : This study was designed to determine the relative activity of basic fibroblast growth factor (bFGF), vascular endothelial growth factor/vascular permeability factor (VEGF/VPF), and interleukin-8 (IL-8) in the process of regulating tumorigenicity and metastasis of transitional cell carcinoma (TCC) of the urinary bladder.
Experimental Design : We selected the specific expression clones as indicated to the expression level of bFGF, VEGF or IL-8 m highly tumorigenic and highly metastatic human TCC cell line 253JB-V. We evaluated transitionally tumorigemcily and production of spontanous lymph node metastases after orthotopic implantation of the specific expression clones. To assess the transitional changes of angiogenesis and the expression of angiogenic factors, intratumor neovascularization and mRNA expression of angiogenic factors were determined in the tumors.
Results : In vitro, the highest and lowest specific expression clones demonstrated stable expression of specific total R … More NA and protein. Following implantation into the bladders of athymic nude mice, the highest bFGF- and the highest IL-8-expressing clone cells acquired increased tumorigenicity in only early stage. Moreover, the tumorigenicity of the lowest bFGF- and the lowest IL-8-expressing clone were consistently inhibited through all stages compared to parental 253JB-V cell lines. The highest bFGF- and the highest IL-8-expressing clone cells relatively acquired matastasis in earlier stage. Moreover, the metastasis of the lowest IL-8-expressing clone was relatively inhibited compared to parental 253JB-V cell lines. However, the tumorigenicity and metastasis of the specific expression clones of VEGF were not significantly different from that of parental 253JB-V cell lines.
In the tumors, each highest expressing clone significantly increased the specific mRNA expression and neovascularity, and each lowest expressing clone significantly decreased specific mRNA expression and neovascularity in only early stage compared to parental 253JB-V cell lines. However, the intratumor neovascularity and the expression level or bFGF, VEGF and IL-8 in the tumor of the specific expression clones were gradually regulated to the same expression level as parental 253JB-V cell lines within 4 weeks.
Conclusions : These findings indicate that the expression of bFGF regulates angiogenesis, tumorigenicity especially in early stage of tumor progression of human TCC growing in the urinary bladder of athymic nude mice. Thereore, this study provided tha evidence that the therapy targeting angiogenesis pathways such as bFGF represents a novel, effective, and promising therapy with significant anti-tumoral effect, in the early stage of tumor progression of TCC in the urinary bladder. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Inoue K, Shuin T, et al.: "Docetaxel (Taxotare) Enhances the Therapeutic Effect of the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Metastatic Human Transitional Cell Carcinoma"Clin Cancer Res.. 9. 886-899 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Shuin T, et al.: "Frequent Administration of Angiogenesis Inhibitor TNP-470 (AGM-1470) at an Optimal Biological Dose Inhibits Tumor Growth and Metastasis of Metastatic Human Transitional Cell Carcinoma in the Urinary Bladder"Clin Cancer Res.. 8. 2389-2398 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, et al.: "Adenoviral-wediated gene therapy of human bladder cancer with antisense interleukin-8"Oncol Rep.. 8. 955-964 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, et al.: "Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma"Clin Cancer Res.. 6. 4874-4848 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, et al.: "Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor"Clin Cancer Res.. 6. 4422-4431 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, et al.: "Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer"Cancer Res.. 60. 2290-2299 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP: "Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer"Cancer Res.. 60. 2290-9 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Perrotte P, Wood CG, Slaton JW, Sweeny P, Dinney CP: "Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor"Clin Cancer Res.. 6. 4422-31 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP: "Pacilitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma"Clin Cancer Res.. 6. 4874-84 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Wood CG, Slaton JW, Karashima T, Sweeney P, Dinney CP: "Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8"Oncol Rep.. 8. 955-64 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.: "Frequent Administration of Angiogenesis Inhibitor TNP-470 (AGM-1470) at an Optimal Bikological Dose Inhibits Tumor Growth and Metastasis of Metastatic Human Transitional Cell Carcinoma in the Urinary Bladder"Clin Cancer Res.. 8. 2389-98 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T: "Docetaxel (Taxotare) Enhances the Therapeutic Effect of the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Metastatic Human Transitional Cell Carcinoma"Clin Cancer Res.. 9. 886-899 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Keiji Inoue: "Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer"Clin Cancer Res. 6(5). 2104-2119 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Keiji Inoue: "Combination Therapy with the Anti-Vascular Endotherial Cell Growth Factor Receptor (flk1/KDR) Monoclonal Antibody DC101 and Paclitaxel for Metastatic Human Transitional Cell Carcinoma"Clin Cancer Res. 6(7). 2635-2643 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Inoue K: "Gene therapy of human bladder cancer with adenovirus-mediated antisense Basic fibroblast growth factor"Clin Cancer Res. 6(11). 4422-4431 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Inoue K: "The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy"Clin Cancer Res. 6(12). 4866-4873 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Inoue K: "Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antbody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma"Clin Cancer Res. 6(12). 4874-4884 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Slaton JW: "Exoression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma"Am J Pathol. 158(2). 735-743 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi